Atlas Venture Associates Opportunity I, L.P.
10% owner at Kymera Therapeutics; 10% owner at Disc Medicine; 10% owner at Xilio Therapeutics.
- Rank
- 182nd of 809
- Companies held
- 3
- Largest holding
- KYMR, 81.6% of total
- Latest SEC filing
- Jan 12, 2024
- Listed but not counted
- $122M
What the $932M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Kymera Therapeutics KYMR Common Stock | Directly | 5,365,563 | $119.39 | $641M | 68.7% | Form 4, Nov 3, 2022 |
| Kymera Therapeutics KYMR Common Stock | Indirectly (see filing footnote) | 1,001,417 | $119.39 | $120M | 12.8% | Form 4, Nov 3, 2022 |
| Disc Medicine IRON Common Stock | Directly | 1,449,686 | $76.11 | $110M | 11.8% | Form 4, Jan 10, 2024 |
| Disc Medicine IRON Common Stock | Indirectly (see filing footnote) | 786,160 | $76.11 | $59.8M | 6.4% | Form 4, Jan 10, 2024 |
| Xilio Therapeutics XLO Common Stock | Directly | 144,307 split-adjusted | $7.51 | $1.1M | 0.1% | Form 4, Jan 12, 2024 |
| Xilio Therapeutics XLO Common Stock | Indirectly (see filing footnote) | 52,487 split-adjusted | $7.51 | $394K | 0.0% | Form 4, Jan 12, 2024 |
Share counts are the amounts Atlas Venture Associates Opportunity I, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Atlas Venture Associates Opportunity I, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Kymera Therapeutics KYMR Common Stock | Through Atlas Venture Opportunity Fund I, L.P. Held by a company or fund the insider manages | 1,022,502 | $119.39 | $122M | — | Form 4, Nov 2, 2022 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 179 | Energy Holding Corp 10% owner, Tecnoglass Holdings | $957M |
| 180 | Adolph Coors CO LLC 10% owner, Molson Coors Beverage | $956M |
| 181 | Two Sigma Management, LLC 10% owner, Hamilton Insurance Group | $943M |
| 182 | Atlas Venture Associates Opportunity I, L.P. 10% owner, Kymera Therapeutics | $932M |
| 183 | Broadwood Capital INC 10% owner, STAAR Surgical | $929M |
| 184 | Teacher Retirement System OF Texas Insider, Life Time Group Holdings | $928M |
| 185 | ASP Amentum Investco LP 10% owner, Amentum Holdings | $923M |
Other Kymera Therapeutics insiders
All KYMR insiders- Nello Mainolfi$79.6MChief Executive Officer. #1805 overall
- Bruce N. Jacobs$29.2MChief Financial Officer. #3859 overall
- Jared Gollob$14.0MChief Medical Officer. #6806 overall
- Ellen Chiniara$9.6MChief Legal Officer. #9086 overall
- Brian Adams$6.0MChief Legal Officer. #7698 overall
- Noah Goodman$5.6MChief Business Officer. #13327 overall
Questions
How much stock does Atlas Venture Associates Opportunity I, L.P. own?
Atlas Venture Associates Opportunity I, L.P. holds $931,801,900 in listed stock based on SEC filings and current prices, mostly Kymera Therapeutics (KYMR). That ranks 182nd on the Stock Rich List.
Is this Atlas Venture Associates Opportunity I, L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.